Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
THDB0206 vs insulin lispro in type 2 diabetes
NCT05834868Phase 3Completed
- Sponsor
- Tonghua Dongbao
- Start
- May 2022
- Primary completion
- Dec 2024
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 3 trial of BioChaperone Lispro in type 2 diabetes mellitus (T2DM), sponsored by Tonghua Dongbao. Started May 2022; status: completed.
02
Drugs
BioChaperone Lispro
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT05834868.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05834868.